A Louisiana man has filed a Biomet M2a Magnum hip implant lawsuit against the medical device manufacturer claiming that his hip implant was inherently defective.

Plaintiff Al S., a resident of Shreveport, La., received hip replacement surgery in early 2011. During his surgery, Al was implanted with the Biomet M2a Magnum hip implant system, a metal-on-metal hip replacement device.

Al claims that Biomet misrepresented to him and his orthopedic surgeon that the Biomet M2a Magnum hip implant system was both safe and effective.

However, he says the Biomet M2a Magnum hip implant system caused him severe pain. As a result he was forced to undergo a revision surgery that was both costly and risky.

Revision surgeries are more complicated and are often much more dangerous than the initial joint replacement surgeries. Hip implant revision surgeries also present more extended complications than joint replacement surgeries, and come with a higher risk of dislocation.

In fact, according to this Biomet M2a Magnum hip implant lawsuit, one study published in the American Journal of Bone and Joint Surgery found that dislocation after hip revision surgery was four times more likely than dislocation after original implant surgery.

This study showed that 14.4% of patients suffered dislocation after hip revision surgery as opposed to only 3.9% of patients after implant surgery.

Al alleges that the original loosening of his hip implant was because the device is inherently defective and that Biomet was aware of the defect. He also claims that the metal-on-metal design causes excessive amounts of cobalt and chromium to corrode and shed from the surfaces of the device into the surrounding tissue.

When these metal pieces shed into the body, the body reacts and begins to reject the device, Al claims. This rejection may present with symptoms of loosening, pain, dislocation and popping sounds.

Also, the metal poisoning, called metallosis, causes the surrounding tissue and bone to begin to die.

Al alleges that while Biomet tested the device, the U.S. Food and Drug Administration never fully approved the Biomet M2a Magnum hip implant. Yet Biomet representatives continued to meet with doctors and medical professionals throughout the U.S. to promote the device.

The plaintiff claims that as a direct result of the defective Biomet M2a Magnum hip implant system he sustained and continues to experience lost wages, medical and hospital expenses, severe and permanent injuries, pain, suffering and emotional distress.

Al claims that Biomet is responsible for negligence, breach of implied warranties, breach of express warranties, and violation of Louisiana’s Consumer Protection Law.

This Biomet M2a Magnum Hip Implant Lawsuit is Case No. 3:17-cv-00443-RLM-MGG in the United States District Court for the Northern District of Indiana, South Bend Division.